(Q51980628)

English

Quality of life and treatment satisfaction after the addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens in treatment-experienced patients with HIV infection.

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10537443

Quality of life and treatment satisfaction after the addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens in treatment-experienced patients with HIV infection. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10537443

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M L Chatterton

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10537443

J Scott-Lennox

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10537443

A W Wu

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10537443

J Scott

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10537443

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10537443

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10537443

15 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10537443

67-74

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10537443

https://scigraph.springernature.com/pub.10.2165/00019053-199915001-00006

0 references

1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of zidovudine plus lamivudine or zalcitabine on health-related quality of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal study on the Quality of Life of symptomatic HIV-infected patients in a trial of zidovudine versus zidovudine and interferon-alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health status and function with zidovudine or zalcitabine as initial therapy for AIDS. A randomized controlled trial. Roche 3300/ACTG 114 Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV).

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Family Foundation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-199915001-00006

0 references

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10537443

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51980628&oldid=1584891007"